Boston Scientific Corp
BSXView Detailed Chart
98.500USD
-1.549-1.54%
Close 04/03, 16:00（ET）Quotes delayed by 15 min
145.24BMarket Cap
78.38P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-1.54%
5 Days
-3.73%
1 Month
-5.09%
6 Months
+16.58%
Year to Date
+10.27%
1 Year
+46.03%
View Detailed Chart
Agency Rating
Analyst Rating
Based on
33
analysts
BUY
Current Rating
116.969
Target Price
16.91%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
91
Total
4
Median
7
Average
Company name
Ratings
Analysts
Boston Scientific Corp
BSX
33
Intuitive Surgical Inc
ISRG
33
Edwards Lifesciences Corp
EW
33
Veeva Systems Inc
VEEV
32
Thermo Fisher Scientific Inc
TMO
32
Danaher Corp
DHR
28
1
2
3
...
18
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Sell
Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.347
Sell
RSI(14)
42.532
Neutral
STOCH(KDJ)(9,3,3)
32.353
Sell
ATR(14)
2.406
Low Volatility
CCI(14)
-119.347
Sell
Williams %R
75.096
Sell
TRIX(12,20)
-0.079
Sell
StochRSI(14)
0.000
Sell
Moving Average
Indicators
Value
Direction
MA5
99.989
Sell
MA10
100.948
Sell
MA20
100.599
Sell
MA50
102.209
Sell
MA100
96.120
Buy
MA200
88.158
Buy
News
More news coming soon, stay tuned...
Company
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. Its MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. Its Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions. It also owns the transcarotid artery revascularization (TCAR) platform.
Company codeBSX
CompanyBoston Scientific Corp
CEOMr. Michael F. (Mike) Mahoney
Websitehttps://www.bostonscientific.com/en-US/Home.html
